SELLAS Life Sciences Group, Inc. (SLS) Q3 2024 Earnings
SLS·Reported November 13, 2024·Before market open
Diluted EPS came in at $-0.10, beat the $-0.13 consensus by $0.03.
Diluted EPS
$-0.10beat by $0.03
Consensus: $-0.13
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about SELLAS Life Sciences Group, Inc.'s Q3 2024 earnings report.
SELLAS Life Sciences Group, Inc. (SLS) reported Q3 2024 earnings on November 13, 2024 before market open.
SELLAS Life Sciences Group, Inc. reported diluted EPS of $-0.10 for Q3 2024.
EPS beat the consensus estimate of $-0.13 by $0.03.
You can read the 10-Q periodic report (0001390478-24-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.